Psyros
Prolight Diagnostics comments on acquisition of competitor
Prolight Diagnostics' Norwegian competitor SpinChip Diagnostics was recently acquired by bioMérieux for EUR 138 million, which constitutes one of the largest...
Prolight's COO: "Pilot line paves the way for scalability"
Prolight Diagnostics recently conducted a business review of the pilot production line...
Patient-centered analyses in focus at Cardiac Markers Dialogue Meeting
Prolight Diagnostics recently participated in the 2024 Cardiac...
Prolight Diagnostics advances towards validation of tests for heart attack diagnostics
Prolight Diagnostics' second quarter report reports significant...
Prolights Diagnostics CEO: "We continue to deliver what we promise"
Prolight Diagnostics CEO Ulf Bladin visited BioStock's studio...
Prolight Diagnostics strengthens the board with experienced business developer
Prolight Diagnostics expands its board of directors with Kiarash Farr, who...
Prolights Diagnostics CTO delighted to receive UK government grant
The NIHR i4i Product Development Award has been awarded to Prolight...
Prolight Diagnostics appoints partner for conducting clinical validation studies
Prolight Diagnostics has hired MDx CRO to...
Prolight Diagnostics completes test card design
Firstly, what are your primary responsibilities in the...
Prolight Diagnostics collaboration with G&H | ITL drives development forward
Prolight Diagnostics has appointed G&H | ITL for...
Prolight's COO comments on the collaboration with FlexMedical Solutions
FlexMedical Solutions
Prolight Diagnostics CTO highlights the potential of Psyros
BioStock interviews Steve Ross, co-founder of Psyros Diagnostics...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
